OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The tumour microenvironment in B cell lymphomas
David W. Scott, Randy D. Gascoyne
Nature reviews. Cancer (2014) Vol. 14, Iss. 8, pp. 517-534
Closed Access | Times Cited: 478
David W. Scott, Randy D. Gascoyne
Nature reviews. Cancer (2014) Vol. 14, Iss. 8, pp. 517-534
Closed Access | Times Cited: 478
Showing 1-25 of 478 citing articles:
Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment
Yunlu Dai, Can Xu, Xiaolian Sun, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 12, pp. 3830-3852
Open Access | Times Cited: 824
Yunlu Dai, Can Xu, Xiaolian Sun, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 12, pp. 3830-3852
Open Access | Times Cited: 824
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Madduri Srinivasarao, Chris V. Galliford, Philip S. Low
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 3, pp. 203-219
Closed Access | Times Cited: 600
Madduri Srinivasarao, Chris V. Galliford, Philip S. Low
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 3, pp. 203-219
Closed Access | Times Cited: 600
Germinal centres and B cell lymphomagenesis
Katia Basso, Riccardo Dalla‐Favera
Nature reviews. Immunology (2015) Vol. 15, Iss. 3, pp. 172-184
Closed Access | Times Cited: 448
Katia Basso, Riccardo Dalla‐Favera
Nature reviews. Immunology (2015) Vol. 15, Iss. 3, pp. 172-184
Closed Access | Times Cited: 448
Pembrolizumab (Keytruda)
Gerry Gin Wai Kwok, Thomas Yau, Joanne Wing Yan Chiu, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 11, pp. 2777-2789
Open Access | Times Cited: 364
Gerry Gin Wai Kwok, Thomas Yau, Joanne Wing Yan Chiu, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 11, pp. 2777-2789
Open Access | Times Cited: 364
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari, David Arpon, Colm Keane, et al.
Blood (2018) Vol. 131, Iss. 16, pp. 1809-1819
Open Access | Times Cited: 274
Frank Vari, David Arpon, Colm Keane, et al.
Blood (2018) Vol. 131, Iss. 16, pp. 1809-1819
Open Access | Times Cited: 274
Genetics of diffuse large B-cell lymphoma
Laura Pasqualucci, Riccardo Dalla‐Favera
Blood (2018) Vol. 131, Iss. 21, pp. 2307-2319
Open Access | Times Cited: 227
Laura Pasqualucci, Riccardo Dalla‐Favera
Blood (2018) Vol. 131, Iss. 21, pp. 2307-2319
Open Access | Times Cited: 227
Follicular lymphoma
Antonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 213
Antonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 213
Heparanase: From basic research to therapeutic applications in cancer and inflammation
Israël Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Drug Resistance Updates (2016) Vol. 29, pp. 54-75
Open Access | Times Cited: 197
Israël Vlodavsky, Preeti Singh, Ilanit Boyango, et al.
Drug Resistance Updates (2016) Vol. 29, pp. 54-75
Open Access | Times Cited: 197
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Chloé B. Steen, Bogdan Luca, Mohammad Shahrokh Esfahani, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1422-1437.e10
Open Access | Times Cited: 183
Chloé B. Steen, Bogdan Luca, Mohammad Shahrokh Esfahani, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1422-1437.e10
Open Access | Times Cited: 183
Immunogenomic Landscape of Hematological Malignancies
Olli Dufva, Petri Pölönen, Oscar Brück, et al.
Cancer Cell (2020) Vol. 38, Iss. 3, pp. 380-399.e13
Open Access | Times Cited: 158
Olli Dufva, Petri Pölönen, Oscar Brück, et al.
Cancer Cell (2020) Vol. 38, Iss. 3, pp. 380-399.e13
Open Access | Times Cited: 158
The immune landscape and response to immune checkpoint blockade therapy in lymphoma
Justin Kline, James Godfrey, Stephen M. Ansell
Blood (2019) Vol. 135, Iss. 8, pp. 523-533
Open Access | Times Cited: 152
Justin Kline, James Godfrey, Stephen M. Ansell
Blood (2019) Vol. 135, Iss. 8, pp. 523-533
Open Access | Times Cited: 152
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 107
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 107
Adenosine-A2A Receptor Pathway in Cancer Immunotherapy
Changfa Sun, Bochu Wang, Shilei Hao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Changfa Sun, Bochu Wang, Shilei Hao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
Kevin Nishimoto, Taylor Barca, Aruna Azameera, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 79
Kevin Nishimoto, Taylor Barca, Aruna Azameera, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 79
Burkitt lymphoma
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 77
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 77
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 53
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 53
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities
Tobias Roider, Marc A. Baertsch, Donnacha Fitzgerald, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 478-489
Open Access | Times Cited: 23
Tobias Roider, Marc A. Baertsch, Donnacha Fitzgerald, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 478-489
Open Access | Times Cited: 23
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment
Jenna M. Kastenschmidt, Joseph G. Schroers‐Martin, Brian J. Sworder, et al.
Cell stem cell (2024) Vol. 31, Iss. 3, pp. 410-420.e4
Open Access | Times Cited: 19
Jenna M. Kastenschmidt, Joseph G. Schroers‐Martin, Brian J. Sworder, et al.
Cell stem cell (2024) Vol. 31, Iss. 3, pp. 410-420.e4
Open Access | Times Cited: 19
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
Andrea J. Radtke, Ekaterina Postovalova, Arina Varlamova, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 444-463.e10
Open Access | Times Cited: 19
Andrea J. Radtke, Ekaterina Postovalova, Arina Varlamova, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 444-463.e10
Open Access | Times Cited: 19
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
Rosalba Camicia, Hans Christian Winkler, Paul O. Hassa
Molecular Cancer (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 150
Rosalba Camicia, Hans Christian Winkler, Paul O. Hassa
Molecular Cancer (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 150
From genetics to the clinic: a translational perspective on follicular lymphoma
Sarah Huet, Pierre Sujobert, Gilles Salles
Nature reviews. Cancer (2018) Vol. 18, Iss. 4, pp. 224-239
Closed Access | Times Cited: 121
Sarah Huet, Pierre Sujobert, Gilles Salles
Nature reviews. Cancer (2018) Vol. 18, Iss. 4, pp. 224-239
Closed Access | Times Cited: 121
A lymphomagenic role for HIV beyond immune suppression?
Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, et al.
Blood (2016) Vol. 127, Iss. 11, pp. 1403-1409
Open Access | Times Cited: 120
Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, et al.
Blood (2016) Vol. 127, Iss. 11, pp. 1403-1409
Open Access | Times Cited: 120
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response
Wendy Béguelin, Matt Teater, Cem Meydan, et al.
Cancer Cell (2020) Vol. 37, Iss. 5, pp. 655-673.e11
Open Access | Times Cited: 120
Wendy Béguelin, Matt Teater, Cem Meydan, et al.
Cancer Cell (2020) Vol. 37, Iss. 5, pp. 655-673.e11
Open Access | Times Cited: 120
DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma
Rada Amin, Frédéric Mourcin, Fabrice Uhel, et al.
Blood (2015) Vol. 126, Iss. 16, pp. 1911-1920
Open Access | Times Cited: 115
Rada Amin, Frédéric Mourcin, Fabrice Uhel, et al.
Blood (2015) Vol. 126, Iss. 16, pp. 1911-1920
Open Access | Times Cited: 115
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
Sabino Ciavarella, M.C. Vegliante, Marco Fabbri, et al.
Annals of Oncology (2018) Vol. 29, Iss. 12, pp. 2363-2370
Open Access | Times Cited: 111
Sabino Ciavarella, M.C. Vegliante, Marco Fabbri, et al.
Annals of Oncology (2018) Vol. 29, Iss. 12, pp. 2363-2370
Open Access | Times Cited: 111
